Sirtuins Explained: The Proteins That Link NAD+ to Longevity

The connection between sirtuins and NAD+ sits at the center of modern longevity biology — these proteins are NAD+-dependent deacylases that can only function when sufficient NAD+ is available as a cofactor, and as NAD+ declines with age, so does sirtuin activity across virtually every tissue in the body. Understanding what sirtuins actually do, and why their declining activity matters, provides the clearest mechanistic rationale for NAD+ precursor supplementation like NMN.

The Evidence Base

The sirtuin field began in yeast, where Sir2 (silent information regulator 2) was found to extend lifespan by up to 70% under caloric restriction. Lin et al. (2000) demonstrated that Sir2 requires NAD+ as a cofactor — a finding that immediately linked nutrient sensing, NAD+ metabolism, and aging biology. The subsequent identification of seven mammalian sirtuins (SIRT1 through SIRT7) opened a wide research program.

The seven mammalian sirtuin isoforms differ in cellular location, enzymatic activity, and primary function.

Sirtuin	Location	Primary Activity	Key Role
SIRT1	Nucleus / Cytoplasm	Deacetylase	Gene regulation, metabolism, DNA repair, longevity signalling
SIRT2	Cytoplasm	Deacetylase	Cell cycle regulation, tubulin deacetylation
SIRT3	Mitochondria	Deacetylase	Mitochondrial metabolism, ROS reduction
SIRT4	Mitochondria	ADP-ribosyltransferase	Fatty acid oxidation regulation
SIRT5	Mitochondria	Desuccinylase / demalonylase	Ammonia detoxification, urea cycle
SIRT6	Nucleus	Deacetylase / mono-ADP-ribosyltransferase	DNA DSB repair, telomere maintenance
SIRT7	Nucleolus	Deacetylase	rRNA transcription, ribosome biogenesis

In humans, much of the direct evidence comes from observational and mechanistic studies rather than large RCTs. What we know from human data: SIRT1 activity in peripheral blood mononuclear cells declines with age (Guarente, 2013). SIRT3 protein in skeletal muscle decreases significantly in older adults compared to younger controls. Caloric restriction — which raises NAMPT expression and NAD+ levels — is consistently associated with preserved sirtuin activity in humans.

The NMN-sirtuin link in humans is less direct but supported by the Yoshino et al. (2021) Science trial, which found that 250 mg/day NMN for 10 weeks improved skeletal muscle insulin sensitivity in postmenopausal women — an effect that correlates mechanistically with SIRT1-mediated metabolic regulation. The Igarashi et al. (2022) npj Aging trial documented elevated blood NAD+ levels and altered muscle gene expression after NMN supplementation in older men, with transcriptomic signatures consistent with increased sirtuin activity.

This is important context: the human evidence for sirtuins is largely mechanistic and indirect. We cannot yet measure sirtuin activity conveniently in clinical settings, which limits our ability to draw direct dose-response conclusions in humans.

The Mechanism: How Sirtuins Use NAD+

Sirtuins are class III histone deacetylases — but they deacylate far more than histones. Their substrates include transcription factors, metabolic enzymes, mitochondrial proteins, and DNA repair machinery. The deacylation reaction consumes NAD+ stoichiometrically: for every acetyl group removed from a substrate, one NAD+ molecule is cleaved into nicotinamide and O-acetyl-ADP-ribose. This means sirtuin activity is directly coupled to intracellular NAD+ availability.

When NAD+ is abundant — as it tends to be in youth, during fasting, or after exercise — sirtuins are active and the downstream consequences are broadly protective: improved mitochondrial efficiency, enhanced DNA repair, reduced inflammation, and better glucose homeostasis. When NAD+ falls, sirtuin activity drops in proportion, and these protective functions decline simultaneously. Gomes et al. (2013) showed this elegantly in mice: declining NAD+ disrupted nuclear-mitochondrial communication via SIRT1, and restoring NAD+ with NMN reversed the phenotype even in old animals.

SIRT1: The Master Metabolic Regulator

SIRT1 is the most extensively studied mammalian sirtuin. Its substrates include PGC-1α (a master regulator of mitochondrial biogenesis), FOXO transcription factors (stress resistance and autophagy), p53 (apoptosis regulation), and NF-κB (inflammatory signaling). By deacetylating these targets, SIRT1 simultaneously promotes mitochondrial health, enhances stress resistance, moderates inflammation, and calibrates cell fate decisions.

The metabolic relevance of SIRT1 is substantial. In the liver, SIRT1 deacetylates PGC-1α to promote gluconeogenesis during fasting while suppressing lipogenic gene expression. In skeletal muscle, SIRT1 activity improves insulin sensitivity — the mechanism most relevant to the Yoshino 2021 trial results. In adipose tissue, SIRT1 inhibits fat storage and promotes fat mobilization. Across these tissues, the common thread is that SIRT1 functions as a nutrient sensor that couples NAD+ availability to metabolic adaptation.

As a practical matter, anything that raises cellular NAD+ — whether fasting, exercise, or NMN supplementation — should theoretically support SIRT1 activity. The human evidence for NMN benefits is most consistent in tissues with high metabolic demand, which aligns with SIRT1's distribution pattern.

SIRT3: The Mitochondrial Sirtuin

SIRT3 is the primary mitochondrial sirtuin and arguably the most directly relevant to aging biology. It is localized to the mitochondrial matrix, where it deacetylates — and thereby activates — multiple components of the electron transport chain, the citric acid cycle, and antioxidant defense systems. SIRT3 activates SOD2 (the primary mitochondrial antioxidant enzyme) by deacetylation, reducing mitochondrial reactive oxygen species production. It also activates isocitrate dehydrogenase, acetyl-CoA synthetase, and complex I components.

SIRT3 knockout mice age faster and develop hallmarks of metabolic syndrome earlier. Conversely, SIRT3 overexpression in mice extends healthspan. In humans, polymorphisms in the SIRT3 gene are associated with longevity in some populations, though this data is preliminary.

The mitochondrial NAD+ pool is distinct from cytoplasmic NAD+ and is maintained separately. NMN can raise both pools, though the relative contribution to mitochondrial vs. cytoplasmic NAD+ is an active area of investigation. Cellular energy production depends critically on the mitochondrial NAD+/NADH ratio, which SIRT3 helps optimize.

SIRT1 and the Circadian Clock

One of the more elegant discoveries in sirtuin biology is SIRT1's role in maintaining circadian rhythm integrity. SIRT1 deacetylates BMAL1 and PER2 — core components of the molecular clock — in a NAD+-dependent manner. This creates a feedback loop: NAMPT (the rate-limiting NAD+ biosynthesis enzyme) is itself a clock-controlled gene, meaning NAD+ oscillates with a circadian rhythm, which drives rhythmic SIRT1 activity, which maintains clock function.

When NAD+ levels decline with age, this circadian NAD+ oscillation dampens, SIRT1 activity becomes less rhythmic, and clock function deteriorates. The practical implication: disrupted circadian biology in aging may be partly a consequence of NAD+ decline rather than an independent process. This is also why the timing of NMN supplementation has attracted interest, though the human timing data is limited. For an overview of the NAD+ aging relationship, the NMN and aging article covers this thoroughly.

The Other Sirtuins: SIRT2, SIRT4, SIRT5, SIRT6, SIRT7

SIRT2 is cytoplasmic and regulates cell cycle progression, tubulin deacetylation, and adipogenesis. SIRT4 is mitochondrial and primarily functions as an ADP-ribosyltransferase rather than a deacetylase; it suppresses amino acid catabolism and acts as a metabolic brake during nutrient availability. SIRT5 deacylates succinate and malonyl groups from mitochondrial proteins, broadly regulating the citric acid cycle. SIRT6 is nuclear and specializes in DNA double-strand break repair via PARP1 regulation and telomere maintenance; SIRT6 overexpression extends male mouse lifespan by 15%. SIRT7 regulates RNA polymerase I transcription and ribosome biogenesis.

The full sirtuin family thus covers virtually every major cellular compartment and function. Their collective dependence on NAD+ means that age-related NAD+ decline is not a single-pathway problem — it affects a distributed regulatory network simultaneously.

Who Benefits Most

The strongest mechanistic case for sirtuin support through NAD+ repletion is in people over 40, where NAD+ decline is measurable and accelerating. The Yoshino 2021 Science trial and Igarashi 2022 npj Aging trial both enrolled adults in this age range and found the clearest biochemical and functional effects. People with metabolic syndrome, insulin resistance, or significant oxidative stress may have particularly depleted NAD+ pools — PARP activation from inflammatory DNA damage competes directly with sirtuins for NAD+ substrate. In these individuals, raising NAD+ may produce more measurable sirtuin-relevant effects than in young, healthy controls with adequate baseline NAD+.

The longevity supplement stack data also suggests that interventions targeting NAD+ are most effective when combined with lifestyle inputs that independently activate sirtuins — specifically caloric restriction, exercise, and time-restricted eating. These behaviors raise NAMPT expression and thus the NAD+ available for sirtuin function, creating synergy with supplemental NMN.

Practical Takeaways

• Sirtuins require NAD+ as a cofactor — their activity is directly limited by NAD+ availability, which declines with age
• SIRT1, SIRT3, and SIRT6 are the most studied in the context of longevity; they regulate metabolism, mitochondrial function, and DNA repair respectively
• Human evidence for sirtuin activation is mostly indirect — we infer sirtuin activity from downstream metabolic and transcriptomic markers, not direct measurement
• NMN raises NAD+ levels in human trials, providing the substrate that sirtuins require, but whether this translates to measurably improved sirtuin activity long-term in healthy adults is not yet established
• Behaviors that activate sirtuins independently — fasting, exercise, caloric restriction — likely synergize with NAD+ precursor supplementation
• Bio:sudo NMN 1000mg provides a clinically relevant dose for supporting NAD+ availability across tissues where sirtuins operate

Bottom Line

Sirtuins are NAD+-dependent enzymes with well-established roles in metabolic regulation, DNA repair, and mitochondrial maintenance — and their activity declines as NAD+ falls with age. The mechanistic case for supporting sirtuin function through NAD+ precursors like NMN is scientifically coherent and supported by preclinical data and some human biochemical evidence. What remains to be established is whether NMN supplementation in healthy adults produces measurable sirtuin-dependent benefits beyond the biochemical markers — that research is ongoing, and the honest answer is that we don't yet have definitive long-term human RCT data.

References

1. Yoshino M, et al. "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science. 2021;372(6547):1224–1229. [Source]
2. Igarashi M, et al. "Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men." npj Aging. 2022;8(1):5. [Source]
3. Irie J, et al. "Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men." Endocrine Journal. 2020;67(2):153–160. [Source]
4. Liao B, et al. "Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners." J Int Soc Sports Nutr. 2021;18(1):54. [Source]
5. Gomes AP, et al. "Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging." Cell. 2013;155(7):1624–1638. [Source]
6. Niu KM, et al. "The impacts of short-term NMN supplementation on serum metabolism, fecal microbiota, and telomere length in pre-aging phase." Nutrients. 2023;15(3):755. [Source]

---

---